Macrophage migration-inhibitory factor is elevated in pregnant women with gestational diabetes mellitus

References

• Gabbe SG. Definition, detection, and management of gestational diabetes. Obstet Gynecol 1986;67:121–125.
   PubMed Web of Science ®Google Scholar
• Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop—Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 1998;21 (Suppl 2):B161–B167.
   Web of Science ®Google Scholar
• American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 2000;23 (Suppl 1):S77–S79.
   Google Scholar
• Dabelea D, Snell-Bergeon JK, Hartsfield CL, Bischoff KJ, Hamman RF, McDuffie RS; Kaiser Permanente of Colorado GDM Screening Program. Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program. Diabetes Care 2005;28:579–584.
   PubMed Web of Science ®Google Scholar
• Ferrara A, Kahn HS, Quesenberry CP, Riley C, Hedderson MM. An increase in the incidence of gestational diabetes mellitus: Northern California, 1991–2000. Obstet Gynecol 2004;103:526–533.
   PubMed Web of Science ®Google Scholar
• Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS; Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005;352:2477–2486.
   PubMed Web of Science ®Google Scholar
• Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabet Med 2004;21:103–113.
   PubMed Web of Science ®Google Scholar
• Lee AJ, Hiscock RJ, Wein P, Walker SP, Permezel M. Gestational diabetes mellitus: clinical predictors and long-term risk of developing type 2 diabetes: a retrospective cohort study using survival analysis. Diabetes Care 2007;30:878–883.
   PubMed Web of Science ®Google Scholar
• ACOG. Guidelines for perinatal care. 4th ed. Washington, DC: American Council of Obstetricians and Gynecologists; 1997.
   Google Scholar
• Dabelea D, Hanson RL, Lindsay RS, Pettitt DJ, Imperatore G, Gabir MM, Roumain J, et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes 2000;49:2208–2211.
   PubMed Web of Science ®Google Scholar
• Catalano PM, Kirwan JP, Haugel-de Mouzon S, King J. Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus. J Nutr 2003;133:1674S–1683S.
   PubMed Web of Science ®Google Scholar
• Bloom BR, Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 1966;153:80–82.
   PubMed Web of Science ®Google Scholar
• David JR. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci USA 1966;56:72–77.
   PubMed Web of Science ®Google Scholar
• Bernhagen J, Calandra T, Mitchell RA, Martin SB, Tracey KJ, Voelter W, Manogue KR, et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 1993;365:756–759.
   PubMed Web of Science ®Google Scholar
• Calandra T, Bernhagen J, Mitchell RA, Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 1994;179:1895–1902.
   PubMed Web of Science ®Google Scholar
• Mikulowska A, Metz CN, Bucala R, Holmdahl R. Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice. J Immunol 1997;158:5514–5517.
   PubMed Web of Science ®Google Scholar
• Shimizu T, Nishihira J, Mizue Y, Nakamura H, Abe R, Watanabe H, Ohkawara A, Shimizu H. High macrophage migration inhibitory factor (MIF) serum levels associated with extended psoriasis. J Invest Dermatol 2001;116:989–990.
   PubMed Web of Science ®Google Scholar
• Nishihira J, Ogata A. Macrophage migration inhibitory factor as a target molecule in multiple sclerosis. Curr Opin Investig Drugs 2001;2:778–782.
   PubMedGoogle Scholar
• Gando S, Nishihira J, Kobayashi S, Morimoto Y, Nanzaki S, Kemmotsu O. Macrophage migration inhibitory factor is a critical mediator of systemic inflammatory response syndrome. Intensive Care Med 2001;27:1187–1193.
   PubMed Web of Science ®Google Scholar
• Taguchi C, Sugita S, Tagawa Y, Nishihira J, Mochizuki M. Macrophage migration inhibitory factor in ocular fluids of patients with uveitis. Br J Ophthalmol 2001;85:1367–1371.
   PubMed Web of Science ®Google Scholar
• Bernhagen J, Bacher M, Calandra T, Metz CN, Doty SB, Donnelly T, Bucala R. An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J Exp Med 1996;183:277–282.
   PubMed Web of Science ®Google Scholar
• Stosic-Grujicic S, Stojanovic I, Maksimovic-Ivanic D, Momcilovic M, Popadic D, Harhaji L, Miljkovic D, et al. Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus. J Cell Physiol 2008;215:665–675.
   PubMed Web of Science ®Google Scholar
• Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, Cerami A, Bucala R. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995;377:68–71.
   PubMed Web of Science ®Google Scholar
• Hanifi-Moghaddam P, Schloot NC, Kappler S, Seissler J, Kolb H. An association of autoantibody status and serum cytokine levels in type 1 diabetes. Diabetes 2003;52:1137–1142.
   PubMed Web of Science ®Google Scholar
• Herder C, Kolb H, Koenig W, Haastert B, Müller-Scholze S, Rathmann W, Holle R, et al. Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg, Survey 4 (KORA S4). Diabetes Care 2006;29:368–371.
   PubMed Web of Science ®Google Scholar
• Herder C, Klopp N, Baumert J, Müller M, Khuseyinova N, Meisinger C, Martin S, et al. Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case-Cohort Study, 1984-2002. Diabetologia 2008;51:276–284.
   PubMed Web of Science ®Google Scholar
• Amoli MM, Donn RP, Thomson W, Hajeer AH, Garcia-Porrua C, Lueiro M, Ollier WE, Gonzalez-Gay MA. Macrophage migration inhibitory factor gene polymorphism is associated with sarcoidosis in biopsy proven erythema nodosum. J Rheumatol 2002;29:1671–1673.
   PubMed Web of Science ®Google Scholar
• Baugh JA, Chitnis S, Donnelly SC, Monteiro J, Lin X, Plant BJ, Wolfe F, et al. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun 2002;3:170–176.
   PubMed Web of Science ®Google Scholar
• Mizue Y, Nishihira J, Miyazaki T, Fujiwara S, Chida M, Nakamura K, Kikuchi K, Mukai M. Quantitation of macrophage migration inhibitory factor (MIF) using the one-step sandwich enzyme immunosorbent assay: elevated serum MIF concentrations in patients with autoimmune diseases and identification of MIF in erythrocytes. Int J Mol Med 2000;5:397–403.
   PubMed Web of Science ®Google Scholar
• Petrovsky N, Socha L, Silva D, Grossman AB, Metz C, Bucala R. Macrophage migration inhibitory factor exhibits a pronounced circadian rhythm relevant to its role as a glucocorticoid counter-regulator. Immunol Cell Biol 2003;81:137–143.
   PubMed Web of Science ®Google Scholar
• Waeber G, Calandra T, Roduit R, Haefliger JA, Bonny C, Thompson N, Thorens B, et al. Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor. Proc Natl Acad Sci USA 1997;94:4782–4787.
   PubMed Web of Science ®Google Scholar
• Vozarova B, Stefan N, Hanson R, Lindsay RS, Bogardus C, Tataranni PA, Metz C, Bucala R. Plasma concentrations of macrophage migration inhibitory factor are elevated in Pima Indians compared to Caucasians and are associated with insulin resistance. Diabetologia 2002;45:1739–1741.
   PubMed Web of Science ®Google Scholar
• Atsumi T, Cho YR, Leng L, McDonald C, Yu T, Danton C, Hong EG, et al. The proinflammatory cytokine macrophage migration inhibitory factor regulates glucose metabolism during systemic inflammation. J Immunol 2007;179:5399–5406.
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA 1994;91:4854–4858.
   PubMed Web of Science ®Google Scholar
• Dandona P, Aljada A, Ghanim H, Mohanty P, Tripathy C, Hofmeyer D, Chaudhuri A. Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin. J Clin Endocrinol Metab 2004;89:5043–5047.
   PubMed Web of Science ®Google Scholar
• Stojanovic I, Lazaroski S, Nicoletti F, Stosic-Grujicic S. Lack of macrophage migration inhibitory factor (MIF) confers resistance to immunoinflammatory diabetes in mice. Diabetologia 2007;50:S187.
   Web of Science ®Google Scholar
• Mitamura Y, Takeuchi S, Matsuda A, Tagawa Y, Mizue Y, Nishihira J. Macrophage migration inhibitory factor levels in the vitreous of patients with proliferative diabetic retinopathy. Br J Ophthalmol 2000;84:636–639.
   PubMed Web of Science ®Google Scholar
• Enquobahrie DA, Williams MA, Qiu C, Meller M, Sorensen TK. Global placental gene expression in gestational diabetes mellitus. Am J Obstet Gynecol 2009;200:206.e1–206.13.
   PubMed Web of Science ®Google Scholar
• Hristoskova S, Holzgreve W, Zhong XY, Hahn S. Macrophage migration inhibition factor is elevated in pregnancy, but not to a greater extent in preeclampsia. Arch Gynecol Obstet 2006;274:25–28.
   PubMedGoogle Scholar
• Khandelwal M, Homko C, Reece EA. Gestational diabetes mellitus: controversies and current opinions. Curr Opin Obstet Gynecol 1999;11:157–165.
   PubMedGoogle Scholar
• Yabunaka N, Nishihira J, Mizue Y, Tsuji M, Kumagai M, Ohtsuka Y, Imamura M, Asaka M. Elevated serum content of macrophage migration inhibitory factor in patients with type 2 diabetes. Diabetes Care 2000;23:256–258.
   PubMed Web of Science ®Google Scholar
• Taricco E, Radaelli T, Nobile de Santis MS, Cetin I. Foetal and placental weights in relation to maternal characteristics in gestational diabetes. Placenta 2003;24:343–347.
   PubMed Web of Science ®Google Scholar
• Kucuk M, Doymaz F. Placental weight and placental weight-to-birth weight ratio are increased in diet- and exercise-treated gestational diabetes mellitus subjects but not in subjects with one abnormal value on 100-g oral glucose tolerance test. J Diabetes Complicat 2009;23:25–31.
   PubMed Web of Science ®Google Scholar